Dr. Alan Shepard, MD

NPI: 1245223767

Inactive Provider

This provider's NPI has been deactivated on 05/07/2026. The information on this page is historical and may no longer be current.

Total Payments
$118,503
2024 Payments
$8,194
Companies
11
Transactions
345
Medicare Patients
3,175
Medicare Billing
$378,441

Payment Breakdown by Category

Other$110,934 (93.6%)
Food & Beverage$4,975 (4.2%)
Travel$2,089 (1.8%)
Consulting$450.00 (0.4%)
Education$54.96 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $107,934 58 91.1%
Food and Beverage $4,975 244 4.2%
Honoraria $3,000 1 2.5%
Travel and Lodging $2,089 35 1.8%
Consulting Fee $450.00 3 0.4%
Education $54.96 4 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $58,449 200 $0 (2024)
Allergan, Inc. $41,802 76 $0 (2021)
EMD Serono, Inc. $14,097 48 $0 (2023)
Upsher-Smith Laboratories LLC $3,246 2 $0 (2017)
Biogen, Inc. $365.73 6 $0 (2023)
Teva Pharmaceuticals USA, Inc. $170.68 4 $0 (2022)
Alkermes, Inc. $150.00 1 $0 (2017)
Avanir Pharmaceuticals, Inc. $109.00 1 $0 (2017)
Assertio Therapeutics, Inc. $54.96 4 $0 (2018)
Biohaven Pharmaceutical Holding Company Ltd. $43.81 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,194 28 ABBVIE INC. ($8,194)
2023 $6,665 41 AbbVie Inc. ($6,487)
2022 $11,351 62 ABBVIE INC. ($11,194)
2021 $41,442 88 AbbVie Inc. ($32,574)
2020 $33,037 70 Allergan, Inc. ($33,007)
2019 $215.05 5 Biogen, Inc. ($150.00)
2018 $7,263 28 EMD Serono, Inc. ($7,024)
2017 $10,336 23 EMD Serono, Inc. ($6,805)

All Payment Transactions

345 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/05/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $18.37 General
Category: NEUROSCIENCE
12/03/2024 ABBVIE INC. QULIPTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
Category: NEUROSCIENCE
11/18/2024 ABBVIE INC. QULIPTA (Drug) Travel and Lodging In-kind items and services $35.63 General
Category: NEUROSCIENCE
11/18/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $26.19 General
Category: NEUROSCIENCE
11/13/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $17.97 General
Category: NEUROSCIENCE
10/24/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $27.99 General
Category: NEUROSCIENCE
10/02/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $21.18 General
Category: NEUROSCIENCE
09/18/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $23.41 General
Category: NEUROSCIENCE
08/30/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $8.31 General
Category: NEUROSCIENCE
08/13/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $14.41 General
Category: NEUROSCIENCE
07/24/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $16.35 General
Category: NEUROSCIENCE
07/02/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $19.66 General
Category: NEUROSCIENCE
06/14/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.04 General
Category: NEUROSCIENCE
05/30/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $22.85 General
Category: NEUROSCIENCE
05/29/2024 ABBVIE INC. UBRELVY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
Category: NEUROSCIENCE
05/07/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $99.25 General
Category: NEUROSCIENCE
05/07/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $21.70 General
Category: NEUROSCIENCE
05/07/2024 ABBVIE INC. UBRELVY (Drug) Travel and Lodging In-kind items and services $20.00 General
Category: NEUROSCIENCE
05/01/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.48 General
Category: NEUROSCIENCE
04/24/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $115.33 General
Category: NEUROSCIENCE
04/17/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.46 General
Category: NEUROSCIENCE
03/21/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $20.06 General
Category: NEUROSCIENCE
03/08/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.06 General
Category: NEUROSCIENCE
02/22/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $19.55 General
Category: NEUROSCIENCE
02/13/2024 ABBVIE INC. UBRELVY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 774 843 $326,930 $88,133
2022 6 770 890 $324,802 $91,323
2021 8 812 941 $322,363 $92,601
2020 7 819 5,597 $396,984 $106,384
Total Patients
3,175
Total Services
8,271
Medicare Billing
$378,441
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 388 457 $147,611 $42,924 29.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 317 317 $160,257 $38,611 24.1%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 31 31 $7,750 $2,927 37.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 18 18 $7,812 $2,258 28.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 20 20 $3,500 $1,413 40.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 407 488 $157,624 $46,633 29.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 293 293 $148,051 $38,584 26.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 30 30 $13,020 $4,676 35.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 15 17 $2,975 $1,006 33.8%
96372 Injection of drug or substance under skin or into muscle Office 2022 13 33 $2,904 $385.00 13.3%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2022 12 29 $228.00 $38.24 16.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 319 319 $161,095 $43,137 26.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 361 412 $133,076 $41,451 31.1%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 43 47 $8,225 $2,866 34.8%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 30 31 $7,750 $2,795 36.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 12 12 $4,644 $863.25 18.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 11 11 $2,409 $790.08 32.8%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 18 55 $4,840 $618.63 12.8%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2021 18 54 $324.00 $80.30 24.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 238 238 $120,448 $30,690 25.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 318 372 $120,156 $28,209 23.5%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2020 12 4,700 $70,500 $22,785 32.3%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 208 229 $57,250 $19,485 34.0%
64615 Injection of chemical for destruction of facial and neck nerve muscles on both sides of face Office 2020 12 24 $21,888 $3,049 13.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 16 18 $3,942 $1,119 28.4%

About Dr. Alan Shepard, MD

Dr. Alan Shepard, MD is a Neurology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245223767.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Shepard, MD has received a total of $118,503 in payments from pharmaceutical and medical device companies, with $8,194 received in 2024. These payments were reported across 345 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($107,934).

As a Medicare-enrolled provider, Shepard has provided services to 3,175 Medicare beneficiaries, totaling 8,271 services with total Medicare billing of $378,441. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Chicago, IL
  • Active Since 08/30/2005
  • Last Updated 01/18/2026
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1245223767

Products in Payments

  • UBRELVY (Drug) $85,523
  • Rebif (Biological) $13,849
  • QULIPTA (Drug) $11,587
  • QUDEXY XR Topiramate Extended Release Capsules (Drug) $3,246
  • BOTOX (Biological) $3,141
  • TYSABRI (Biological) $365.73
  • AJOVY (Drug) $143.53
  • NUEDEXTA (Drug) $109.00
  • NURTEC ODT (Drug) $59.58
  • Cambia (Drug) $54.96
  • Mavenclad (Biological) $45.35
  • AJOVY (Biological) $27.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Chicago